These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

650 related items for PubMed ID: 24102185

  • 1. Development and characterization of lecithin stabilized glibenclamide nanocrystals for enhanced solubility and drug delivery.
    Kumar BS, Saraswathi R, Kumar KV, Jha SK, Venkates DP, Dhanaraj SA.
    Drug Deliv; 2014 May; 21(3):173-84. PubMed ID: 24102185
    [Abstract] [Full Text] [Related]

  • 2. Development of novel polymer-stabilized diosmin nanosuspensions: in vitro appraisal and ex vivo permeation.
    Freag MS, Elnaggar YS, Abdallah OY.
    Int J Pharm; 2013 Sep 15; 454(1):462-71. PubMed ID: 23830765
    [Abstract] [Full Text] [Related]

  • 3. Development and characterization of nanoparticles of glibenclamide by solvent displacement method.
    Dora CP, Singh SK, Kumar S, Datusalia AK, Deep A.
    Acta Pol Pharm; 2010 Sep 15; 67(3):283-90. PubMed ID: 20524431
    [Abstract] [Full Text] [Related]

  • 4. Development of prednisone:polyethylene glycol 6000 fast-release tablets from solid dispersions: solid-state characterization, dissolution behavior, and formulation parameters.
    Leonardi D, Barrera MG, Lamas MC, Salomón CJ.
    AAPS PharmSciTech; 2007 Dec 14; 8(4):E108. PubMed ID: 18181529
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Enhanced dissolution of megestrol acetate microcrystals prepared by antisolvent precipitation process using hydrophilic additives.
    Cho E, Cho W, Cha KH, Park J, Kim MS, Kim JS, Park HJ, Hwang SJ.
    Int J Pharm; 2010 Aug 30; 396(1-2):91-8. PubMed ID: 20558265
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Amorphous solid dispersion of berberine with absorption enhancer demonstrates a remarkable hypoglycemic effect via improving its bioavailability.
    Zhaojie M, Ming Z, Shengnan W, Xiaojia B, Hatch GM, Jingkai G, Li C.
    Int J Pharm; 2014 Jun 05; 467(1-2):50-9. PubMed ID: 24607213
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Preparation and characterization of gliclazide-polyethylene glycol 4000 solid dispersions.
    Patil MP, Gaikwad NJ.
    Acta Pharm; 2009 Mar 05; 59(1):57-65. PubMed ID: 19304558
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. A Self-nanoemulsifying Drug Delivery System for Poorly Water Soluble Tolbutamide: Development, Optimization and Pharmacodynamic Studies.
    Pandita D, Kumari N, Lather V.
    Pharm Nanotechnol; 2017 Mar 05; 5(4):285-300. PubMed ID: 28925888
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.